Sano Medical disclosure disclosure of the 2022 semi -annual report to achieve revenue of 110 million yuan

On August 29, A -share listed company Sano Medical (code: 688108.SH) released the semi -annual performance report of 2022.

From January 1, 2022-June 30, 2022, the company realized operating income of 110 million yuan, an increase of 40.28%year-on-year, and a net loss of 712.348 million yuan. The loss decreased by 12.64%year-on-year.

The company's industry is a medical device.

During the company's reporting period, the total assets at the end of the period were 1.065 billion yuan, the operating profit was -95.4873 million yuan, and the accounts receivable was 20.559 million yuan.The cash was 114 million yuan.

Sano Medical, the company's full name, Sano Medical Science and Technology Co., Ltd., was established on September 21, 2007. The current general manager Sun Jianhua, the main business is high -end interventional medical device research and development, production, and sales.

- END -